BioArctic AB (publ) (FRA:B9A)

BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of EUR 2.90 billion. The enterprise value is 2.70 billion.

Market Cap	2.90B
Enterprise Value	2.70B

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	55.80M

Valuation Ratios

The trailing PE ratio is 30.70 and the forward PE ratio is 605.57.

PE Ratio	30.70
Forward PE	605.57
PS Ratio	15.70
PB Ratio	15.96
P/TBV Ratio	15.96
P/FCF Ratio	n/a
P/OCF Ratio	21.93
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	28.58
EV / Sales	14.42
EV / EBITDA	n/a
EV / EBIT	20.82
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.02.

Current Ratio	4.78
Quick Ratio	4.21
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	36.52

Financial Efficiency

Return on equity (ROE) is 71.44% and return on invested capital (ROIC) is 58.45%.

Return on Equity (ROE)	71.44%
Return on Assets (ROA)	46.93%
Return on Invested Capital (ROIC)	58.45%
Return on Capital Employed (ROCE)	67.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.41M
Profits Per Employee	721,112
Employee Count	122
Asset Turnover	1.08
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 21.55 million in taxes.

Income Tax	21.55M
Effective Tax Rate	18.58%

Stock Price Statistics

The stock price has increased by +53.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+53.82%
50-Day Moving Average	29.97
200-Day Moving Average	24.02
Relative Strength Index (RSI)	56.49
Average Volume (20 Days)	21

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of EUR 184.72 million and earned 94.47 million in profits. Earnings per share was 1.06.

Revenue	184.72M
Gross Profit	179.25M
Operating Income	127.92M
Pretax Income	116.02M
Net Income	94.47M
EBITDA	n/a
EBIT	127.92M
Earnings Per Share (EPS)	1.06

Balance Sheet

The company has 202.40 million in cash and 4.07 million in debt, with a net cash position of 198.33 million.

Cash & Cash Equivalents	202.40M
Total Debt	4.07M
Net Cash	198.33M
Net Cash Per Share	n/a
Equity (Book Value)	181.76M
Book Value Per Share	2.05
Working Capital	181.68M

Cash Flow

Operating Cash Flow	132.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 97.04%, with operating and profit margins of 69.25% and 51.14%.

Gross Margin	97.04%
Operating Margin	69.25%
Pretax Margin	62.81%
Profit Margin	51.14%
EBITDA Margin	n/a
EBIT Margin	69.25%
FCF Margin	n/a

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	-0.25%
Earnings Yield	3.26%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6